Health Care Costs and Treatment Patterns Associated with Uterine Fibroids and Heavy Menstrual Bleeding: A Claims Analysis

por Wang, Alice, Wang, Siting, Owens, Charlotte D., Vora, Jamie B., Diamond, Michael P.
Publicado 2022

Efficacy and safety of elagolix with add-back therapy in women with uterine fibroids and coexisting adenomyosis

por Muneyyirci-Delale, Ozgul, Archer, David F., Owens, Charlotte D., Barnhart, Kurt T., Bradley, Linda D., Feinberg, Eve, Gillispie, Veronica, Hurtado, Sandra, Kim, Jin Hee, Wang, Alice, Wang, Hui, Stewart, Elizabeth A.
Publicado 2021

Reduction of Heavy Menstrual Bleeding in Women Not Designated as Responders to Elagolix Plus Add Back Therapy for Uterine Fibroids

por Stewart, Elizabeth A., Archer, David F., Owens, Charlotte D., Barnhart, Kurt T., Bradley, Linda D., Feinberg, Eve C., Gillispie-Bell, Veronica, Imudia, Anthony N., Liu, Ran, Kim, Jin Hee, Al-Hendy, Ayman
Publicado 2022

Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids

por Al-Hendy, Ayman, Bradley, Linda, Owens, Charlotte D., Wang, Hui, Barnhart, Kurt T., Feinberg, Eve, Schlaff, William D., Puscheck, Elizabeth E., Wang, Alice, Gillispie, Veronica, Hurtado, Sandra, Muneyyirci-Delale, Ozgul, Archer, David F., Carr, Bruce R., Simon, James A., Stewart, Elizabeth A.
Publicado 2021

Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas

por Simon, James A., Al-Hendy, Ayman, Archer, David F., Barnhart, Kurt T., Bradley, Linda D., Carr, Bruce R., Dayspring, Thomas, Feinberg, Eve C., Gillispie, Veronica, Hurtado, Sandra, Kim, JinHee, Liu, Ran, Owens, Charlotte D., Muneyyirci-Delale, Ozgul, Wang, Alice, Watts, Nelson B., Schlaff, William D.
Publicado 2020